Keywords: phyton, expands, paclitaxel, deal, b-ms, inc, privately-held

Phyton expands paclitaxel deal with B-MS

Article | 15 July 2002

Phyton Inc, a privately-held US biotechnology company focused on theproduction of high-value chemical compounds through its proprietary plant cell fermentation ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing

Related Drugs

Paclitaxel

Taxol

Go to drug listing